Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
Moderna, Inc. (NASDAQ:MRNA) has delivered a major boost to its turnaround story. Its personalized mRNA cancer vaccine, Intismeran,…
Moderna Shares Skyrocket 90% Toward Best Day Ever—Here’s Why
Topline Moderna’s stock soared by more than 90% as trading opened Wednesday, nearly doubling the biotech giant’s share…